A phase 0 study of ribociclib in patients with recurrent glioblastoma seeks to inform the feasibility of the use of CDK 4/6 inhibitors for deadly brain tumors.
Devona Williams, PharmD, BCOP
Devona is a freelance medical writer and owner of D Script Medical Writing, LLC. She has over 20 years of professional experience as a clinical pharmacist. Devona has extensive pharmacy and project writing exposure in stem cell transplant, oncology, and infectious disease. Her portfolio includes medical education modules and continuing education materials for student, prescriber, and pharmacist audiences. She is a board-certified oncology pharmacist who earned bachelor of science in pharmacy and doctor of pharmacy degrees from the Winkle College of Pharmacy in Cincinnati, Ohio.